IP Library Granted Patent US 7,125,658
Granted Patent B2
US 7,125,658 · App. 09/814,661 · Granted Oct 24, 2006

Small protein that interacts with a ribonucleotide reductase subunit and uses thereof

Assignee: The Trustees of Columbia University in the City of New York
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,125,658
App. No.
09/814,661
Granted
Oct 24, 2006
Kind
B2
Abstract

The present invention provides for an isolated Sml1 protein or a homologue thereof. The present invention also provides for a screening assay for identifying compounds that are capable of reducing the division rate of a cell by altering an interaction between a ribonucleotide reductase and a Sml1 protein in the cell, which comprises: (a) contacting the cell with a compound, (b) comparing the division rate of the cell in step (a) with the division rate of the cell in the absence of the compound so as to determine whether the compound alters the interaction between the ribonucleotide reductase and the Sml1 protein of the cell, thereby reducing the cell division rate of the cell.

Claims (6)

1. A screening assay for identifying a compound that is capable of reducing the division rate of a cell which comprises:

(a) contacting the cell with a compound, wherein the compound consists of a fragment of the Sml1 protein or a peptidomimetic of the Sml1 protein, determined to mimic the binding of Sml1 protein to the large subunit of ribonucleotide reductase (Rnr1), which Sml1 protein comprises amino acids having the amino acid sequence set forth in SEQ ID NO: 2, and

(b) comparing the division rate of the cell in step (a) with the division rate of the cell in the absence of the compound so as to determine whether the compound reduces the division rate of the cell, thereby identifying a compound capable of reducing the division rate of the cell.

2. The screening assay of claim 1 , wherein the fragment is from about 20 amino acids to about 90 amino acids in length.

3. The screening assay of claim 1 , wherein the cell is a yeast cell, a mammalian cell, a plant cell, an insect cell or a microbe.

4. The screening assay of claim 3 , wherein the mammalian cell is a human cell, a hamster cell, a mouse cell, a rat cell or a monkey cell.

Assignments (3)
CONFIRMATORY LICENSE Recorded Jun 21, 2017
From: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 042769/0476 →
CONFIRMATORY LICENSE Recorded Apr 13, 2009
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022537/0090 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2001
From: ROTHSTEIN, RODNEY; ZHAO, XIAOLAN
To: TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK,THE
Reel/Frame 012078/0435 →
Continuity (3)
Continuation PCTUS992226000 · Sep 24, 1999
Continuation In Part 0915985800 · Sep 24, 1998
Related Publication 20020151016A1 · Oct 17, 2002